CaTe is a medical device manufacturing company that uses AI and IoT to develop and sell remote cardiac rehabilitation systems.
CaTe has raised $10.7M in total funding. The most recent round was Series B. The last funding was announced in August 2025.
CaTe's investors include Mizuho Capital, Mitsubishi UFJ Capital, JIC Venture Growth Investments, Samurai Incubate, Kiraboshi Capital.
CaTe is headquartered in Hongo, Japan.
CaTe is a medical device manufacturing company that uses AI and IoT to develop and sell remote cardiac rehabilitation systems.
CaTe is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CaTe — Funding & Investors." VCBacked, August 27, 2025, https://www.vcbacked.co/company/cate. Accessed September 2, 2026.
VCBacked. (2025). CaTe — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/cate
{{cite web |title=CaTe — Funding & Investors |url=https://www.vcbacked.co/company/cate |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated